| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 6.75e-07 | 21 | 17 | 3 | GO:0042975 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 6.82e-07 | 2 | 17 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 6.82e-07 | 2 | 17 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 2.05e-06 | 3 | 17 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 4.15e-06 | 303 | 17 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 4.60e-06 | 562 | 17 | 6 | GO:0003712 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 1.95e-05 | 417 | 17 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 7.12e-05 | 15 | 17 | 2 | GO:0010484 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 9.56e-05 | 582 | 17 | 5 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 1.28e-04 | 20 | 17 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 2.36e-04 | 27 | 17 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 2.70e-04 | 1160 | 17 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 2.73e-04 | 29 | 17 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.19e-04 | 753 | 17 | 5 | GO:0008134 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 4.46e-04 | 37 | 17 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 4.99e-04 | 187 | 17 | 3 | GO:0016922 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 6.26e-04 | 1356 | 17 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 8.49e-04 | 51 | 17 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 9.51e-04 | 54 | 17 | 2 | GO:0001223 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 9.87e-04 | 55 | 17 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 1.17e-03 | 60 | 17 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 1.33e-03 | 64 | 17 | 2 | GO:0140296 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.42e-03 | 66 | 17 | 2 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.42e-03 | 66 | 17 | 2 | GO:0001098 | |
| GeneOntologyMolecularFunction | p53 binding | 1.92e-03 | 77 | 17 | 2 | GO:0002039 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.97e-03 | 78 | 17 | 2 | GO:0008080 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 2.28e-03 | 84 | 17 | 2 | GO:0003684 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.39e-03 | 86 | 17 | 2 | GO:0046332 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.01e-03 | 739 | 17 | 4 | GO:0003682 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 3.34e-03 | 102 | 17 | 2 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 3.47e-03 | 104 | 17 | 2 | GO:0016407 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 6.20e-03 | 140 | 17 | 2 | GO:0001221 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 8.71e-03 | 167 | 17 | 2 | GO:0031490 | |
| GeneOntologyMolecularFunction | histone modifying activity | 1.59e-02 | 229 | 17 | 2 | GO:0140993 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 1.71e-02 | 238 | 17 | 2 | GO:0016747 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 2.26e-02 | 276 | 17 | 2 | GO:0003730 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 9.36e-07 | 231 | 17 | 5 | GO:0006352 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 2.99e-06 | 35 | 17 | 3 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 2.99e-06 | 35 | 17 | 3 | GO:0030511 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 3.83e-06 | 4 | 17 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 1.39e-05 | 186 | 17 | 4 | GO:0006367 | |
| GeneOntologyBiologicalProcess | cellular response to heat | 3.81e-05 | 81 | 17 | 3 | GO:0034605 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 6.63e-05 | 1390 | 17 | 7 | GO:0045944 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid acetylation | 7.62e-05 | 16 | 17 | 2 | GO:0006474 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to heat | 7.62e-05 | 16 | 17 | 2 | GO:1900034 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 9.93e-05 | 999 | 17 | 6 | GO:0071824 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.08e-04 | 115 | 17 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | response to heat | 1.26e-04 | 121 | 17 | 3 | GO:0009408 | |
| GeneOntologyBiologicalProcess | stimulatory C-type lectin receptor signaling pathway | 1.60e-04 | 23 | 17 | 2 | GO:0002223 | |
| GeneOntologyBiologicalProcess | cellular response to lectin | 1.60e-04 | 23 | 17 | 2 | GO:1990858 | |
| GeneOntologyBiologicalProcess | response to lectin | 1.60e-04 | 23 | 17 | 2 | GO:1990840 | |
| GeneOntologyBiologicalProcess | peptidyl-lysine acetylation | 2.39e-04 | 28 | 17 | 2 | GO:0018394 | |
| GeneOntologyBiologicalProcess | N-terminal protein amino acid modification | 2.56e-04 | 29 | 17 | 2 | GO:0031365 | |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 4.90e-04 | 192 | 17 | 3 | GO:0017015 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 5.13e-04 | 195 | 17 | 3 | GO:1903844 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 5.14e-04 | 41 | 17 | 2 | GO:0060325 | |
| GeneOntologyBiologicalProcess | placenta blood vessel development | 5.93e-04 | 44 | 17 | 2 | GO:0060674 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 6.19e-04 | 208 | 17 | 3 | GO:0009266 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 7.05e-04 | 48 | 17 | 2 | GO:0060323 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 7.96e-04 | 51 | 17 | 2 | GO:0030521 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 9.04e-04 | 237 | 17 | 3 | GO:0019827 | |
| GeneOntologyBiologicalProcess | protein destabilization | 9.59e-04 | 56 | 17 | 2 | GO:0031648 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.60e-04 | 242 | 17 | 3 | GO:0098727 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.04e-03 | 249 | 17 | 3 | GO:0065004 | |
| GeneOntologyBiologicalProcess | face development | 1.21e-03 | 63 | 17 | 2 | GO:0060324 | |
| GeneOntologyBiologicalProcess | body morphogenesis | 1.25e-03 | 64 | 17 | 2 | GO:0010171 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.29e-03 | 65 | 17 | 2 | GO:0045815 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.40e-03 | 276 | 17 | 3 | GO:0007179 | |
| GeneOntologyBiologicalProcess | protein acetylation | 1.41e-03 | 68 | 17 | 2 | GO:0006473 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.41e-03 | 68 | 17 | 2 | GO:0141137 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 1.49e-03 | 70 | 17 | 2 | GO:0060261 | |
| GeneOntologyBiologicalProcess | RNA polymerase II preinitiation complex assembly | 1.54e-03 | 71 | 17 | 2 | GO:0051123 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 1.80e-03 | 77 | 17 | 2 | GO:2000144 | |
| GeneOntologyBiologicalProcess | innate immune response-activating signaling pathway | 1.99e-03 | 312 | 17 | 3 | GO:0002758 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 1.99e-03 | 81 | 17 | 2 | GO:0060260 | |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 2.19e-03 | 85 | 17 | 2 | GO:0070897 | |
| GeneOntologyBiologicalProcess | activation of innate immune response | 2.40e-03 | 333 | 17 | 3 | GO:0002218 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | 2.40e-03 | 333 | 17 | 3 | GO:0051054 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 2.46e-03 | 336 | 17 | 3 | GO:0071560 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 2.51e-03 | 91 | 17 | 2 | GO:2000142 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.61e-03 | 343 | 17 | 3 | GO:0071559 | |
| GeneOntologyBiologicalProcess | positive regulation of programmed cell death | 2.68e-03 | 739 | 17 | 4 | GO:0043068 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.69e-03 | 347 | 17 | 3 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 2.73e-03 | 95 | 17 | 2 | GO:2000781 | |
| GeneOntologyBiologicalProcess | embryo implantation | 2.84e-03 | 97 | 17 | 2 | GO:0007566 | |
| GeneOntologyBiologicalProcess | cellular response to UV | 2.84e-03 | 97 | 17 | 2 | GO:0034644 | |
| GeneOntologyCellularComponent | transcription regulator complex | 8.62e-05 | 596 | 17 | 5 | GO:0005667 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.29e-03 | 272 | 17 | 3 | GO:0090575 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 2.60e-03 | 94 | 17 | 2 | GO:0000123 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 2.71e-03 | 96 | 17 | 2 | GO:0010494 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 3.18e-03 | 104 | 17 | 2 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 3.48e-03 | 109 | 17 | 2 | GO:1902493 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | 3.91e-03 | 1377 | 17 | 5 | GO:0140513 | |
| GeneOntologyCellularComponent | transferase complex | 6.58e-03 | 963 | 17 | 4 | GO:1990234 | |
| HumanPheno | Aortic isthmus hypoplasia | 7.71e-07 | 2 | 5 | 2 | HP:0034227 | |
| HumanPheno | Plantar crease between first and second toes | 7.71e-07 | 2 | 5 | 2 | HP:0008107 | |
| HumanPheno | High axial triradius | 7.71e-07 | 2 | 5 | 2 | HP:0001042 | |
| HumanPheno | Humoral immunodeficiency | 2.31e-06 | 3 | 5 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 2.31e-06 | 3 | 5 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 2.31e-06 | 3 | 5 | 2 | HP:0005895 | |
| HumanPheno | Laryngeal cartilage malformation | 2.31e-06 | 3 | 5 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 2.31e-06 | 3 | 5 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 2.31e-06 | 3 | 5 | 2 | HP:0000756 | |
| HumanPheno | Trichiasis | 4.62e-06 | 4 | 5 | 2 | HP:0001128 | |
| HumanPheno | Widened distal phalanges | 4.62e-06 | 4 | 5 | 2 | HP:0006200 | |
| HumanPheno | Visceral hemangioma | 4.62e-06 | 4 | 5 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 4.62e-06 | 4 | 5 | 2 | HP:0011087 | |
| HumanPheno | Vascular ring | 4.62e-06 | 4 | 5 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 4.62e-06 | 4 | 5 | 2 | HP:0031207 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 7.70e-06 | 5 | 5 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 7.70e-06 | 5 | 5 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 7.70e-06 | 5 | 5 | 2 | HP:0030421 | |
| HumanPheno | Large foramen magnum | 1.15e-05 | 6 | 5 | 2 | HP:0002700 | |
| HumanPheno | Deviated nasal septum | 1.62e-05 | 7 | 5 | 2 | HP:0004411 | |
| HumanPheno | Pilomatrixoma | 2.77e-05 | 9 | 5 | 2 | HP:0030434 | |
| HumanPheno | Cervical cord compression | 2.77e-05 | 9 | 5 | 2 | HP:0002341 | |
| HumanPheno | Frontal hirsutism | 3.46e-05 | 10 | 5 | 2 | HP:0011335 | |
| HumanPheno | Obstructive sleep apnea | 3.51e-05 | 79 | 5 | 3 | HP:0002870 | |
| HumanPheno | Abnormal subclavian artery morphology | 4.22e-05 | 11 | 5 | 2 | HP:0031251 | |
| HumanPheno | Facial grimacing | 5.99e-05 | 13 | 5 | 2 | HP:0000273 | |
| HumanPheno | Keloids | 5.99e-05 | 13 | 5 | 2 | HP:0010562 | |
| HumanPheno | Sandal gap | 6.31e-05 | 96 | 5 | 3 | HP:0001852 | |
| HumanPheno | Parietal foramina | 6.98e-05 | 14 | 5 | 2 | HP:0002697 | |
| HumanPheno | Duplication of phalanx of hallux | 6.98e-05 | 14 | 5 | 2 | HP:0010066 | |
| HumanPheno | Hypoplastic aortic arch | 6.98e-05 | 14 | 5 | 2 | HP:0012304 | |
| HumanPheno | Social and occupational deterioration | 8.05e-05 | 15 | 5 | 2 | HP:0007086 | |
| HumanPheno | Duplication of phalanx of toe | 8.05e-05 | 15 | 5 | 2 | HP:0010181 | |
| HumanPheno | Square face | 9.20e-05 | 16 | 5 | 2 | HP:0000321 | |
| HumanPheno | Premature thelarche | 1.04e-04 | 17 | 5 | 2 | HP:0010314 | |
| HumanPheno | Facial hirsutism | 1.17e-04 | 18 | 5 | 2 | HP:0009937 | |
| HumanPheno | Skin appendage neoplasm | 1.17e-04 | 18 | 5 | 2 | HP:0012842 | |
| HumanPheno | Bicuspid aortic valve | 1.20e-04 | 119 | 5 | 3 | HP:0001647 | |
| HumanPheno | Agenesis of corpus callosum | 1.22e-04 | 365 | 5 | 4 | HP:0001274 | |
| HumanPheno | Abnormal aortic valve cusp morphology | 1.26e-04 | 121 | 5 | 3 | HP:0031567 | |
| HumanPheno | Absent earlobe | 1.45e-04 | 20 | 5 | 2 | HP:0000387 | |
| HumanPheno | Abnormal lateral ventricle morphology | 1.53e-04 | 129 | 5 | 3 | HP:0030047 | |
| HumanPheno | Long eyelashes | 1.53e-04 | 129 | 5 | 3 | HP:0000527 | |
| HumanPheno | Localized hirsutism | 1.61e-04 | 21 | 5 | 2 | HP:0009889 | |
| HumanPheno | Deep plantar creases | 1.61e-04 | 21 | 5 | 2 | HP:0001869 | |
| HumanPheno | Corneal scarring | 1.61e-04 | 21 | 5 | 2 | HP:0000559 | |
| HumanPheno | Dysplastic corpus callosum | 1.67e-04 | 395 | 5 | 4 | HP:0006989 | |
| HumanPheno | Abnormal foramen magnum morphology | 1.93e-04 | 23 | 5 | 2 | HP:0002699 | |
| HumanPheno | Agenesis of permanent teeth | 1.93e-04 | 23 | 5 | 2 | HP:0006349 | |
| HumanPheno | Neoplasm of the liver | 1.95e-04 | 140 | 5 | 3 | HP:0002896 | |
| HumanPheno | Simple ear | 2.11e-04 | 24 | 5 | 2 | HP:0020206 | |
| HumanPheno | Broad hallux phalanx | 2.11e-04 | 24 | 5 | 2 | HP:0010059 | |
| HumanPheno | Low anterior hairline | 2.26e-04 | 147 | 5 | 3 | HP:0000294 | |
| HumanPheno | Shawl scrotum | 2.29e-04 | 25 | 5 | 2 | HP:0000049 | |
| HumanPheno | Minor feet anomalies | 2.48e-04 | 26 | 5 | 2 | HP:0010613 | |
| HumanPheno | Abnormal feet morphology | 2.48e-04 | 26 | 5 | 2 | HP:0010611 | |
| HumanPheno | Phonophobia | 2.48e-04 | 26 | 5 | 2 | HP:0002183 | |
| HumanPheno | Perimembranous ventricular septal defect | 2.48e-04 | 26 | 5 | 2 | HP:0011682 | |
| HumanPheno | Thick eyebrow | 2.59e-04 | 154 | 5 | 3 | HP:0000574 | |
| HumanPheno | Flared iliac wing | 2.68e-04 | 27 | 5 | 2 | HP:0002869 | |
| HumanPheno | Broad distal phalanx of finger | 2.68e-04 | 27 | 5 | 2 | HP:0009836 | |
| HumanPheno | Short columella | 3.10e-04 | 29 | 5 | 2 | HP:0002000 | |
| HumanPheno | Abnormal parietal bone morphology | 3.10e-04 | 29 | 5 | 2 | HP:0002696 | |
| HumanPheno | Broad eyebrow | 3.10e-04 | 29 | 5 | 2 | HP:0011229 | |
| HumanPheno | Abnormality of upper lip vermillion | 3.16e-04 | 464 | 5 | 4 | HP:0011339 | |
| HumanPheno | Avascular necrosis of the capital femoral epiphysis | 3.32e-04 | 30 | 5 | 2 | HP:0005743 | |
| HumanPheno | Abnormal epididymis morphology | 3.32e-04 | 30 | 5 | 2 | HP:0009714 | |
| HumanPheno | Preaxial foot polydactyly | 3.32e-04 | 30 | 5 | 2 | HP:0001841 | |
| HumanPheno | Sleep apnea | 3.36e-04 | 168 | 5 | 3 | HP:0010535 | |
| HumanPheno | Sleep-related breathing disorders | 3.42e-04 | 169 | 5 | 3 | HP:5200283 | |
| HumanPheno | Hypoplastic iliac wing | 3.54e-04 | 31 | 5 | 2 | HP:0002866 | |
| HumanPheno | Abnormal distal phalanx morphology of finger | 3.72e-04 | 174 | 5 | 3 | HP:0009832 | |
| HumanPheno | Frontal upsweep of hair | 4.02e-04 | 33 | 5 | 2 | HP:0002236 | |
| HumanPheno | Syringomyelia | 4.02e-04 | 33 | 5 | 2 | HP:0003396 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 4.02e-04 | 33 | 5 | 2 | HP:0011587 | |
| HumanPheno | Aspiration | 4.27e-04 | 34 | 5 | 2 | HP:0002835 | |
| HumanPheno | Abnormality of the helix | 4.32e-04 | 183 | 5 | 3 | HP:0000380 | |
| HumanPheno | Abnormal number of permanent teeth | 4.53e-04 | 35 | 5 | 2 | HP:0011044 | |
| HumanPheno | Abnormal 5th finger morphology | 4.54e-04 | 509 | 5 | 4 | HP:0004207 | |
| HumanPheno | Ventricular septal defect | 4.58e-04 | 510 | 5 | 4 | HP:0001629 | |
| HumanPheno | Hydrocele testis | 4.79e-04 | 36 | 5 | 2 | HP:0000034 | |
| HumanPheno | Disturbance of facial expression | 4.79e-04 | 36 | 5 | 2 | HP:0005324 | |
| HumanPheno | Abnormality of the distal phalanx of the thumb | 4.79e-04 | 36 | 5 | 2 | HP:0009617 | |
| HumanPheno | Nasolacrimal duct obstruction | 4.79e-04 | 36 | 5 | 2 | HP:0000579 | |
| HumanPheno | Abnormal ventricular septum morphology | 4.97e-04 | 521 | 5 | 4 | HP:0010438 | |
| HumanPheno | Auditory sensitivity | 5.06e-04 | 37 | 5 | 2 | HP:0025112 | |
| HumanPheno | Accessory spleen | 5.06e-04 | 37 | 5 | 2 | HP:0001747 | |
| HumanPheno | Auditory hypersensitivity | 5.06e-04 | 37 | 5 | 2 | HP:5200060 | |
| HumanPheno | Nasogastric tube feeding in infancy | 5.06e-04 | 37 | 5 | 2 | HP:0011470 | |
| HumanPheno | Congenital malformation of the great arteries | 5.28e-04 | 529 | 5 | 4 | HP:0011603 | |
| HumanPheno | Natal tooth | 5.34e-04 | 38 | 5 | 2 | HP:0000695 | |
| HumanPheno | Capillary hemangioma | 5.63e-04 | 39 | 5 | 2 | HP:0005306 | |
| HumanPheno | Cellular immunodeficiency | 5.63e-04 | 39 | 5 | 2 | HP:0005374 | |
| HumanPheno | Poor coordination | 5.63e-04 | 39 | 5 | 2 | HP:0002370 | |
| HumanPheno | Highly arched eyebrow | 6.14e-04 | 206 | 5 | 3 | HP:0002553 | |
| HumanPheno | Abnormal hair whorl | 6.53e-04 | 42 | 5 | 2 | HP:0010721 | |
| HumanPheno | Abnormal helix morphology | 6.68e-04 | 212 | 5 | 3 | HP:0011039 | |
| HumanPheno | Juvenile aseptic necrosis | 6.85e-04 | 43 | 5 | 2 | HP:0100323 | |
| HumanPheno | Tube feeding | 6.96e-04 | 215 | 5 | 3 | HP:0033454 | |
| HumanPheno | Single transverse palmar crease | 6.96e-04 | 215 | 5 | 3 | HP:0000954 | |
| MousePheno | thin myocardium compact layer | 7.19e-06 | 46 | 12 | 3 | MP:0004057 | |
| MousePheno | prenatal lethality prior to heart atrial septation, incomplete penetrance | 1.42e-05 | 410 | 12 | 5 | MP:0031660 | |
| MousePheno | embryonic lethality, incomplete penetrance | 1.42e-05 | 410 | 12 | 5 | MP:0011102 | |
| MousePheno | abnormal myocardium compact layer morphology | 2.24e-05 | 67 | 12 | 3 | MP:0004056 | |
| MousePheno | ventricle myocardium hypoplasia | 2.67e-05 | 71 | 12 | 3 | MP:0010502 | |
| MousePheno | myocardium hypoplasia | 4.75e-05 | 86 | 12 | 3 | MP:0010500 | |
| MousePheno | embryonic lethality during organogenesis, incomplete penetrance | 5.79e-05 | 268 | 12 | 4 | MP:0011108 | |
| MousePheno | ventricular hypoplasia | 7.24e-05 | 99 | 12 | 3 | MP:0000279 | |
| MousePheno | heart hypoplasia | 8.14e-05 | 103 | 12 | 3 | MP:0002740 | |
| MousePheno | abnormal epicardium morphology | 9.12e-05 | 17 | 12 | 2 | MP:0003057 | |
| MousePheno | pericardial effusion | 1.02e-04 | 111 | 12 | 3 | MP:0005312 | |
| MousePheno | abnormal ventricle myocardium morphology | 1.16e-04 | 116 | 12 | 3 | MP:0010499 | |
| MousePheno | small heart | 1.17e-04 | 321 | 12 | 4 | MP:0002188 | |
| MousePheno | thin ventricle myocardium compact layer | 1.27e-04 | 20 | 12 | 2 | MP:0010556 | |
| MousePheno | absent myocardial trabeculae | 1.55e-04 | 22 | 12 | 2 | MP:0000293 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 1.61e-04 | 1124 | 12 | 6 | MP:0011112 | |
| MousePheno | perinatal lethality | 1.66e-04 | 1130 | 12 | 6 | MP:0002081 | |
| MousePheno | abnormal myocardial trabeculae morphology | 2.20e-04 | 144 | 12 | 3 | MP:0002189 | |
| MousePheno | prenatal lethality, incomplete penetrance | 2.49e-04 | 747 | 12 | 5 | MP:0011101 | |
| MousePheno | abnormal spongiotrophoblast size | 2.52e-04 | 28 | 12 | 2 | MP:0012097 | |
| MousePheno | effusion | 2.58e-04 | 152 | 12 | 3 | MP:0021205 | |
| MousePheno | abnormal myocardium layer morphology | 3.11e-04 | 414 | 12 | 4 | MP:0005329 | |
| MousePheno | abnormal heart layer morphology | 3.34e-04 | 422 | 12 | 4 | MP:0010545 | |
| MousePheno | lethality throughout fetal growth and development | 3.75e-04 | 435 | 12 | 4 | MP:0006208 | |
| MousePheno | oligodactyly | 4.92e-04 | 39 | 12 | 2 | MP:0000565 | |
| MousePheno | embryonic lethality during organogenesis | 5.22e-04 | 876 | 12 | 5 | MP:0006207 | |
| MousePheno | abnormal cardiac muscle tissue morphology | 5.85e-04 | 489 | 12 | 4 | MP:0010630 | |
| MousePheno | lethality throughout fetal growth and development, incomplete penetrance | 6.47e-04 | 208 | 12 | 3 | MP:0011109 | |
| MousePheno | perinatal lethality, incomplete penetrance | 6.51e-04 | 503 | 12 | 4 | MP:0011090 | |
| MousePheno | increased megakaryocyte cell number | 6.55e-04 | 45 | 12 | 2 | MP:0008254 | |
| MousePheno | abnormal embryo size | 7.81e-04 | 956 | 12 | 5 | MP:0001697 | |
| MousePheno | abnormal pericardium morphology | 8.13e-04 | 225 | 12 | 3 | MP:0000288 | |
| MousePheno | open neural tube | 8.24e-04 | 226 | 12 | 3 | MP:0000929 | |
| MousePheno | abnormal vascular development | 8.63e-04 | 542 | 12 | 4 | MP:0000259 | |
| MousePheno | decreased birth body size | 8.89e-04 | 232 | 12 | 3 | MP:0009703 | |
| MousePheno | abnormal vitelline vasculature morphology | 9.22e-04 | 235 | 12 | 3 | MP:0003229 | |
| MousePheno | abnormal vasculogenesis | 9.43e-04 | 54 | 12 | 2 | MP:0001622 | |
| MousePheno | abnormal birth body size | 9.45e-04 | 237 | 12 | 3 | MP:0009701 | |
| MousePheno | ventricular septal defect | 1.25e-03 | 261 | 12 | 3 | MP:0010402 | |
| MousePheno | abnormal adipose tissue amount | 1.35e-03 | 1077 | 12 | 5 | MP:0005452 | |
| MousePheno | abnormal prenatal body size | 1.58e-03 | 1116 | 12 | 5 | MP:0010866 | |
| MousePheno | abnormal spongiotrophoblast layer morphology | 1.67e-03 | 72 | 12 | 2 | MP:0004255 | |
| MousePheno | increased grooming behavior | 1.76e-03 | 74 | 12 | 2 | MP:0001441 | |
| MousePheno | decreased embryo size | 1.79e-03 | 659 | 12 | 4 | MP:0001698 | |
| MousePheno | abnormal hematopoietic precursor cell morphology | 1.85e-03 | 299 | 12 | 3 | MP:0013707 | |
| MousePheno | postnatal lethality, incomplete penetrance | 1.89e-03 | 669 | 12 | 4 | MP:0011086 | |
| MousePheno | abnormal trabecula carnea morphology | 1.96e-03 | 78 | 12 | 2 | MP:0004067 | |
| MousePheno | abnormal placenta junctional zone morphology | 2.06e-03 | 80 | 12 | 2 | MP:0008957 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 2.23e-03 | 700 | 12 | 4 | MP:0011098 | |
| MousePheno | thin myocardium | 2.32e-03 | 85 | 12 | 2 | MP:0002652 | |
| MousePheno | abnormal megakaryocyte morphology | 2.37e-03 | 86 | 12 | 2 | MP:0002417 | |
| MousePheno | atrial septal defect | 2.48e-03 | 88 | 12 | 2 | MP:0010403 | |
| MousePheno | perimembraneous ventricular septal defect | 2.71e-03 | 92 | 12 | 2 | MP:0010418 | |
| MousePheno | abnormal interventricular septum morphology | 2.71e-03 | 342 | 12 | 3 | MP:0000281 | |
| MousePheno | abnormal interventricular septum membranous part morphology | 2.77e-03 | 93 | 12 | 2 | MP:0008823 | |
| MousePheno | embryonic growth arrest | 2.80e-03 | 346 | 12 | 3 | MP:0001730 | |
| MousePheno | abnormal embryonic growth/weight/body size | 3.08e-03 | 1295 | 12 | 5 | MP:0002088 | |
| MousePheno | abnormal bone marrow hematopoietic cell morphology | 3.32e-03 | 102 | 12 | 2 | MP:0013660 | |
| MousePheno | abnormal heart development | 3.44e-03 | 372 | 12 | 3 | MP:0000267 | |
| MousePheno | abnormal heart ventricle morphology | 3.53e-03 | 793 | 12 | 4 | MP:0005294 | |
| MousePheno | abnormal neural tube closure | 3.60e-03 | 378 | 12 | 3 | MP:0003720 | |
| MousePheno | abnormal interatrial septum morphology | 3.64e-03 | 107 | 12 | 2 | MP:0000282 | |
| MousePheno | abnormal cardiovascular development | 3.67e-03 | 802 | 12 | 4 | MP:0002925 | |
| MousePheno | abnormal adipose tissue morphology | 3.83e-03 | 1361 | 12 | 5 | MP:0000003 | |
| MousePheno | pale yolk sac | 3.85e-03 | 110 | 12 | 2 | MP:0001722 | |
| MousePheno | abnormal heart septum morphology | 3.87e-03 | 388 | 12 | 3 | MP:0006113 | |
| MousePheno | abnormal hematopoietic stem cell morphology | 3.98e-03 | 112 | 12 | 2 | MP:0004808 | |
| MousePheno | abnormal fluid regulation | 4.09e-03 | 826 | 12 | 4 | MP:0001784 | |
| MousePheno | adipose tissue phenotype | 4.11e-03 | 1383 | 12 | 5 | MP:0005375 | |
| MousePheno | decreased birth weight | 4.63e-03 | 121 | 12 | 2 | MP:0009674 | |
| MousePheno | abnormal birth weight | 4.78e-03 | 123 | 12 | 2 | MP:0009672 | |
| MousePheno | decreased thymocyte number | 5.09e-03 | 127 | 12 | 2 | MP:0000715 | |
| MousePheno | decreased fibroblast proliferation | 5.25e-03 | 129 | 12 | 2 | MP:0011704 | |
| MousePheno | abnormal prenatal growth/weight/body size | 5.74e-03 | 1493 | 12 | 5 | MP:0004196 | |
| MousePheno | abnormal extraembryonic tissue morphology | 5.74e-03 | 908 | 12 | 4 | MP:0002086 | |
| MousePheno | abnormal grooming behavior | 5.90e-03 | 137 | 12 | 2 | MP:0001440 | |
| MousePheno | thin ventricular wall | 5.98e-03 | 138 | 12 | 2 | MP:0000280 | |
| Domain | - | 7.80e-07 | 2 | 17 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 7.80e-07 | 2 | 17 | 2 | PF02135 | |
| Domain | ZF_TAZ | 7.80e-07 | 2 | 17 | 2 | PS50134 | |
| Domain | - | 7.80e-07 | 2 | 17 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 7.80e-07 | 2 | 17 | 2 | IPR010303 | |
| Domain | KAT11 | 7.80e-07 | 2 | 17 | 2 | SM01250 | |
| Domain | Nuc_rcpt_coact_CREBbp | 7.80e-07 | 2 | 17 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 7.80e-07 | 2 | 17 | 2 | PF08214 | |
| Domain | - | 7.80e-07 | 2 | 17 | 2 | 1.10.1630.10 | |
| Domain | KIX | 7.80e-07 | 2 | 17 | 2 | PS50952 | |
| Domain | Znf_TAZ | 7.80e-07 | 2 | 17 | 2 | IPR000197 | |
| Domain | KIX_dom | 7.80e-07 | 2 | 17 | 2 | IPR003101 | |
| Domain | Creb_binding | 7.80e-07 | 2 | 17 | 2 | PF09030 | |
| Domain | KIX | 7.80e-07 | 2 | 17 | 2 | PF02172 | |
| Domain | ZnF_TAZ | 7.80e-07 | 2 | 17 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 7.80e-07 | 2 | 17 | 2 | IPR031162 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 7.80e-07 | 2 | 17 | 2 | IPR013178 | |
| Domain | CBP_P300_HAT | 7.80e-07 | 2 | 17 | 2 | PS51727 | |
| Domain | DUF902 | 7.80e-07 | 2 | 17 | 2 | PF06001 | |
| Domain | SUZ | 4.67e-06 | 4 | 17 | 2 | IPR024771 | |
| Domain | SUZ | 4.67e-06 | 4 | 17 | 2 | PS51673 | |
| Domain | Nuc_rcpt_coact | 1.17e-05 | 6 | 17 | 2 | IPR009110 | |
| Domain | R3H | 2.80e-05 | 9 | 17 | 2 | SM00393 | |
| Domain | R3H | 4.27e-05 | 11 | 17 | 2 | PS51061 | |
| Domain | R3H | 4.27e-05 | 11 | 17 | 2 | PF01424 | |
| Domain | R3H_dom | 4.27e-05 | 11 | 17 | 2 | IPR001374 | |
| Domain | - | 4.27e-05 | 11 | 17 | 2 | 3.30.1370.50 | |
| Domain | ZF_ZZ_1 | 1.18e-04 | 18 | 17 | 2 | PS01357 | |
| Domain | ZF_ZZ_2 | 1.18e-04 | 18 | 17 | 2 | PS50135 | |
| Domain | ZZ | 1.18e-04 | 18 | 17 | 2 | PF00569 | |
| Domain | ZnF_ZZ | 1.32e-04 | 19 | 17 | 2 | SM00291 | |
| Domain | Znf_ZZ | 1.32e-04 | 19 | 17 | 2 | IPR000433 | |
| Domain | Bromodomain_CS | 2.50e-04 | 26 | 17 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 5.10e-04 | 37 | 17 | 2 | PS00633 | |
| Domain | Bromodomain | 5.38e-04 | 38 | 17 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 6.26e-04 | 41 | 17 | 2 | PS50014 | |
| Domain | BROMO | 6.57e-04 | 42 | 17 | 2 | SM00297 | |
| Domain | Bromodomain | 6.57e-04 | 42 | 17 | 2 | IPR001487 | |
| Domain | - | 6.57e-04 | 42 | 17 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 6.31e-07 | 18 | 14 | 3 | M26942 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 1.12e-06 | 84 | 14 | 4 | M1008 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.19e-06 | 22 | 14 | 3 | MM1370 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.56e-06 | 24 | 14 | 3 | M13404 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 2.00e-06 | 26 | 14 | 3 | M2499 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.31e-06 | 110 | 14 | 4 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 4.38e-06 | 118 | 14 | 4 | M27316 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 9.14e-06 | 5 | 14 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 9.14e-06 | 5 | 14 | 2 | M48020 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 9.14e-06 | 5 | 14 | 2 | M27228 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 9.14e-06 | 5 | 14 | 2 | M48023 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.37e-05 | 6 | 14 | 2 | M22062 | |
| Pathway | REACTOME_HEME_SIGNALING | 1.40e-05 | 49 | 14 | 3 | M41832 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 1.92e-05 | 7 | 14 | 2 | MM1573 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 2.56e-05 | 8 | 14 | 2 | M22058 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 2.56e-05 | 8 | 14 | 2 | M48022 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 2.56e-05 | 8 | 14 | 2 | M48024 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 2.56e-05 | 8 | 14 | 2 | M46443 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 3.28e-05 | 9 | 14 | 2 | M47451 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.28e-05 | 65 | 14 | 3 | M39682 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 4.10e-05 | 10 | 14 | 2 | M27945 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 4.10e-05 | 70 | 14 | 3 | M938 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 5.01e-05 | 11 | 14 | 2 | MM1521 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 5.01e-05 | 11 | 14 | 2 | M48021 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 5.01e-05 | 11 | 14 | 2 | M26924 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 6.01e-05 | 12 | 14 | 2 | M7968 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.01e-05 | 12 | 14 | 2 | M27765 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 6.01e-05 | 12 | 14 | 2 | M22006 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 6.59e-05 | 82 | 14 | 3 | M2 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 8.28e-05 | 14 | 14 | 2 | M27808 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 9.55e-05 | 15 | 14 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 9.55e-05 | 15 | 14 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 9.55e-05 | 15 | 14 | 2 | MM1439 | |
| Pathway | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | 9.55e-05 | 15 | 14 | 2 | M953 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.09e-04 | 16 | 14 | 2 | M1296 | |
| Pathway | BIOCARTA_IL7_PATHWAY | 1.09e-04 | 16 | 14 | 2 | MM1420 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.09e-04 | 16 | 14 | 2 | M8516 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.09e-04 | 16 | 14 | 2 | M27121 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES | 1.09e-04 | 16 | 14 | 2 | M27940 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 1.12e-04 | 98 | 14 | 3 | M48247 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.24e-04 | 17 | 14 | 2 | MM1509 | |
| Pathway | REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA | 1.24e-04 | 17 | 14 | 2 | M48025 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 1.55e-04 | 19 | 14 | 2 | M18933 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES | 1.55e-04 | 19 | 14 | 2 | M46442 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.72e-04 | 20 | 14 | 2 | M27881 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 1.90e-04 | 21 | 14 | 2 | M39593 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 1.90e-04 | 21 | 14 | 2 | M27485 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 2.04e-04 | 120 | 14 | 3 | M48233 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.09e-04 | 22 | 14 | 2 | MM1443 | |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | 2.15e-04 | 122 | 14 | 3 | M29689 | |
| Pathway | BIOCARTA_NTHI_PATHWAY | 2.29e-04 | 23 | 14 | 2 | M2821 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.71e-04 | 25 | 14 | 2 | M27880 | |
| Pathway | PID_HDAC_CLASSIII_PATHWAY | 2.94e-04 | 26 | 14 | 2 | M32 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 3.17e-04 | 27 | 14 | 2 | M26943 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 3.41e-04 | 28 | 14 | 2 | M27254 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.66e-04 | 29 | 14 | 2 | M48076 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.87e-04 | 149 | 14 | 3 | M27888 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 3.92e-04 | 30 | 14 | 2 | M207 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | 3.92e-04 | 30 | 14 | 2 | M936 | |
| Pathway | WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR | 4.47e-04 | 32 | 14 | 2 | M39521 | |
| Pathway | WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA | 5.05e-04 | 34 | 14 | 2 | M39771 | |
| Pathway | PID_HIF2PATHWAY | 5.05e-04 | 34 | 14 | 2 | M44 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.05e-04 | 34 | 14 | 2 | MM15531 | |
| Pathway | REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES | 5.35e-04 | 35 | 14 | 2 | M48246 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 5.98e-04 | 37 | 14 | 2 | M27797 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 6.31e-04 | 38 | 14 | 2 | M27757 | |
| Pathway | REACTOME_HSF1_DEPENDENT_TRANSACTIVATION | 6.31e-04 | 38 | 14 | 2 | M27255 | |
| Pathway | PID_FOXM1_PATHWAY | 6.99e-04 | 40 | 14 | 2 | M176 | |
| Pathway | PID_IFNG_PATHWAY | 6.99e-04 | 40 | 14 | 2 | M161 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 7.71e-04 | 42 | 14 | 2 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 7.71e-04 | 42 | 14 | 2 | M27172 | |
| Pathway | PID_HNF3A_PATHWAY | 8.46e-04 | 44 | 14 | 2 | M285 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 8.46e-04 | 44 | 14 | 2 | M27295 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 9.65e-04 | 47 | 14 | 2 | M7946 | |
| Pathway | PID_HES_HEY_PATHWAY | 1.01e-03 | 48 | 14 | 2 | M288 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.01e-03 | 48 | 14 | 2 | M611 | |
| Pathway | PID_FOXO_PATHWAY | 1.05e-03 | 49 | 14 | 2 | M136 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.05e-03 | 49 | 14 | 2 | M618 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 1.05e-03 | 210 | 14 | 3 | M41836 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.18e-03 | 52 | 14 | 2 | M2404 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 1.20e-03 | 220 | 14 | 3 | M27794 | |
| Pathway | PID_NFAT_3PATHWAY | 1.23e-03 | 53 | 14 | 2 | M113 | |
| Pathway | PID_AR_TF_PATHWAY | 1.23e-03 | 53 | 14 | 2 | M151 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.23e-03 | 53 | 14 | 2 | MM15880 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.32e-03 | 55 | 14 | 2 | M39351 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.32e-03 | 55 | 14 | 2 | M27145 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 1.32e-03 | 55 | 14 | 2 | M27001 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.47e-03 | 58 | 14 | 2 | M29616 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.49e-03 | 237 | 14 | 3 | M27786 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS | 1.52e-03 | 59 | 14 | 2 | M39886 | |
| Pathway | PID_P53_REGULATION_PATHWAY | 1.52e-03 | 59 | 14 | 2 | M261 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.57e-03 | 60 | 14 | 2 | M41830 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.59e-03 | 1432 | 14 | 6 | M509 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 1.73e-03 | 63 | 14 | 2 | MM15613 | |
| Pathway | REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA | 1.78e-03 | 64 | 14 | 2 | M27046 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.82e-03 | 254 | 14 | 3 | M27131 | |
| Pathway | PID_RB_1PATHWAY | 1.84e-03 | 65 | 14 | 2 | M279 | |
| Pathway | PID_HIF1_TFPATHWAY | 1.89e-03 | 66 | 14 | 2 | M255 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 1.89e-03 | 66 | 14 | 2 | M101 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 1.89e-03 | 66 | 14 | 2 | M27938 | |
| Pubmed | 7.50e-11 | 152 | 17 | 6 | 38360978 | ||
| Pubmed | 9.69e-10 | 5 | 17 | 3 | 11912212 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.14e-08 | 351 | 17 | 6 | 38297188 | |
| Pubmed | 1.60e-08 | 11 | 17 | 3 | 10454579 | ||
| Pubmed | 2.13e-08 | 12 | 17 | 3 | 12189208 | ||
| Pubmed | 3.55e-08 | 425 | 17 | 6 | 24999758 | ||
| Pubmed | 4.40e-08 | 15 | 17 | 3 | 10567404 | ||
| Pubmed | 5.18e-08 | 453 | 17 | 6 | 29656893 | ||
| Pubmed | 6.57e-08 | 17 | 17 | 3 | 28291835 | ||
| Pubmed | 1.10e-07 | 20 | 17 | 3 | 11877444 | ||
| Pubmed | 1.28e-07 | 21 | 17 | 3 | 19596656 | ||
| Pubmed | 1.61e-07 | 549 | 17 | 6 | 38280479 | ||
| Pubmed | Composite co-activator ARC mediates chromatin-directed transcriptional activation. | 1.71e-07 | 23 | 17 | 3 | 10235267 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 27881875 | ||
| Pubmed | Expression of the nuclear coactivators CBP and p300 in developing craniofacial tissue. | 2.25e-07 | 2 | 17 | 2 | 11963968 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 2.25e-07 | 2 | 17 | 2 | 34845315 | |
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 2.25e-07 | 2 | 17 | 2 | 34813504 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19729597 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15860545 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9528808 | ||
| Pubmed | Analysis of genetic stability at the EP300 and CREBBP loci in a panel of cancer cell lines. | 2.25e-07 | 2 | 17 | 2 | 12696060 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 29460469 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 20301699 | ||
| Pubmed | Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer. | 2.25e-07 | 2 | 17 | 2 | 24551300 | |
| Pubmed | CBP Is Required for Establishing Adaptive Gene Programs in the Adult Mouse Brain. | 2.25e-07 | 2 | 17 | 2 | 36109165 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24639469 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 37816914 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 12242694 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 33911074 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9018065 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24648406 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30135524 | ||
| Pubmed | Binding of p300/CBP co-activators by polyoma large T antigen. | 2.25e-07 | 2 | 17 | 2 | 11438528 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10918613 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31182547 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 35502657 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 39287984 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30635043 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31898871 | ||
| Pubmed | Distribution of co-activators CBP and p300 during mouse oocyte and embryo development. | 2.25e-07 | 2 | 17 | 2 | 16596650 | |
| Pubmed | Phenotype and genotype in 52 patients with Rubinstein-Taybi syndrome caused by EP300 mutations. | 2.25e-07 | 2 | 17 | 2 | 27648933 | |
| Pubmed | Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity. | 2.25e-07 | 2 | 17 | 2 | 30888860 | |
| Pubmed | Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer. | 2.25e-07 | 2 | 17 | 2 | 27881443 | |
| Pubmed | The p300 and CBP Transcriptional Coactivators Are Required for β-Cell and α-Cell Proliferation. | 2.25e-07 | 2 | 17 | 2 | 29217654 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19272189 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10610021 | ||
| Pubmed | Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. | 2.25e-07 | 2 | 17 | 2 | 37314181 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 20717166 | ||
| Pubmed | Distinct roles for CREB-binding protein and p300 in hematopoietic stem cell self-renewal. | 2.25e-07 | 2 | 17 | 2 | 12397173 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10049825 | ||
| Pubmed | CBP/p300 TAZ1 domain forms a structured scaffold for ligand binding. | 2.25e-07 | 2 | 17 | 2 | 15641773 | |
| Pubmed | Differential contribution of p300 and CBP to regulatory element acetylation in mESCs. | 2.25e-07 | 2 | 17 | 2 | 32690000 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9733868 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 30953353 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21803292 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9811832 | ||
| Pubmed | CBP/p300 acetyltransferase activity in hematologic malignancies. | 2.25e-07 | 2 | 17 | 2 | 27380996 | |
| Pubmed | CREBBP and p300 lysine acetyl transferases in the DNA damage response. | 2.25e-07 | 2 | 17 | 2 | 29170789 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24089570 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 25893291 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 11559821 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21555743 | ||
| Pubmed | Rubinstein-Taybi syndrome in Chinese population with four novel mutations. | 2.25e-07 | 2 | 17 | 2 | 33063428 | |
| Pubmed | CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. | 2.25e-07 | 2 | 17 | 2 | 12646247 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 34506759 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22177454 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15706485 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 32576962 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19822209 | ||
| Pubmed | AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer. | 2.25e-07 | 2 | 17 | 2 | 39266679 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 24522976 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 22303793 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 11867645 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 2.25e-07 | 2 | 17 | 2 | 21847097 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 34732714 | ||
| Pubmed | Targeting histone acetylation dynamics and oncogenic transcription by catalytic P300/CBP inhibition. | 2.25e-07 | 2 | 17 | 2 | 34019788 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15598887 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 6.74e-07 | 3 | 17 | 2 | 14716005 | |
| Pubmed | The acetate/ACSS2 switch regulates HIF-2 stress signaling in the tumor cell microenvironment. | 6.74e-07 | 3 | 17 | 2 | 25689462 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 18070920 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11973335 | ||
| Pubmed | Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock. | 6.74e-07 | 3 | 17 | 2 | 14960326 | |
| Pubmed | The acetylation of transcription factor HBP1 by p300/CBP enhances p16INK4A expression. | 6.74e-07 | 3 | 17 | 2 | 21967847 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9194564 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 15171256 | ||
| Pubmed | p300/CBP acts as a coactivator of the cone-rod homeobox transcription factor. | 6.74e-07 | 3 | 17 | 2 | 10708567 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 16428436 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22523253 | ||
| Pubmed | Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. | 6.74e-07 | 3 | 17 | 2 | 11823864 | |
| Pubmed | CBP and p300 are essential for renin cell identity and morphological integrity of the kidney. | 6.74e-07 | 3 | 17 | 2 | 19252086 | |
| Pubmed | An essential role for p300/CBP in the cellular response to hypoxia. | 6.74e-07 | 3 | 17 | 2 | 8917528 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19948376 | ||
| Pubmed | E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin κ locus. | 6.74e-07 | 3 | 17 | 2 | 22544934 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27903646 | ||
| Pubmed | Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP. | 6.74e-07 | 3 | 17 | 2 | 10673499 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 12748286 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10347196 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10075656 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 20452968 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 24340053 | ||
| Interaction | EYA4 interactions | 3.20e-08 | 243 | 17 | 6 | int:EYA4 | |
| Interaction | NCOA6 interactions | 1.04e-07 | 145 | 17 | 5 | int:NCOA6 | |
| Interaction | EGR2 interactions | 2.36e-07 | 171 | 17 | 5 | int:EGR2 | |
| Interaction | AR interactions | 5.47e-07 | 992 | 17 | 8 | int:AR | |
| Interaction | FEV interactions | 5.54e-07 | 203 | 17 | 5 | int:FEV | |
| Interaction | SOX9 interactions | 1.14e-06 | 97 | 17 | 4 | int:SOX9 | |
| Interaction | SMAD1 interactions | 1.34e-06 | 243 | 17 | 5 | int:SMAD1 | |
| Interaction | ING1 interactions | 1.46e-06 | 103 | 17 | 4 | int:ING1 | |
| Interaction | CRX interactions | 1.67e-06 | 254 | 17 | 5 | int:CRX | |
| Interaction | TBXT interactions | 2.34e-06 | 116 | 17 | 4 | int:TBXT | |
| Interaction | HNF4A interactions | 2.47e-06 | 275 | 17 | 5 | int:HNF4A | |
| Interaction | TP53BP1 interactions | 3.21e-06 | 533 | 17 | 6 | int:TP53BP1 | |
| Interaction | E2F5 interactions | 3.50e-06 | 36 | 17 | 3 | int:E2F5 | |
| Interaction | KLF1 interactions | 3.81e-06 | 37 | 17 | 3 | int:KLF1 | |
| Interaction | FOS interactions | 4.57e-06 | 312 | 17 | 5 | int:FOS | |
| Interaction | EWSR1 interactions | 4.75e-06 | 906 | 17 | 7 | int:EWSR1 | |
| Interaction | NCOA1 interactions | 5.85e-06 | 146 | 17 | 4 | int:NCOA1 | |
| Interaction | PAX6 interactions | 9.94e-06 | 366 | 17 | 5 | int:PAX6 | |
| Interaction | NFATC1 interactions | 1.02e-05 | 168 | 17 | 4 | int:NFATC1 | |
| Interaction | TLX1 interactions | 1.20e-05 | 175 | 17 | 4 | int:TLX1 | |
| Interaction | TEAD1 interactions | 1.22e-05 | 176 | 17 | 4 | int:TEAD1 | |
| Interaction | SMAD2 interactions | 1.27e-05 | 385 | 17 | 5 | int:SMAD2 | |
| Interaction | BCL3 interactions | 1.34e-05 | 56 | 17 | 3 | int:BCL3 | |
| Interaction | TPRX2 interactions | 1.34e-05 | 56 | 17 | 3 | int:TPRX2 | |
| Interaction | ALG13 interactions | 1.43e-05 | 183 | 17 | 4 | int:ALG13 | |
| Interaction | NFIA interactions | 1.59e-05 | 188 | 17 | 4 | int:NFIA | |
| Interaction | CTBP1 interactions | 1.64e-05 | 406 | 17 | 5 | int:CTBP1 | |
| Interaction | KLF5 interactions | 1.83e-05 | 195 | 17 | 4 | int:KLF5 | |
| Interaction | ARPP21 interactions | 1.87e-05 | 8 | 17 | 2 | int:ARPP21 | |
| Interaction | WWTR1 interactions | 1.98e-05 | 422 | 17 | 5 | int:WWTR1 | |
| Interaction | GATA2 interactions | 1.99e-05 | 199 | 17 | 4 | int:GATA2 | |
| Interaction | NUP35 interactions | 2.02e-05 | 424 | 17 | 5 | int:NUP35 | |
| Interaction | TRIP4 interactions | 2.27e-05 | 206 | 17 | 4 | int:TRIP4 | |
| Interaction | CNOT3 interactions | 2.32e-05 | 207 | 17 | 4 | int:CNOT3 | |
| Interaction | HOXB3 interactions | 2.40e-05 | 9 | 17 | 2 | int:HOXB3 | |
| Interaction | ARGFX interactions | 2.40e-05 | 9 | 17 | 2 | int:ARGFX | |
| Interaction | GCM1 interactions | 2.42e-05 | 68 | 17 | 3 | int:GCM1 | |
| Interaction | ETV4 interactions | 2.52e-05 | 69 | 17 | 3 | int:ETV4 | |
| Interaction | SMAD3 interactions | 2.61e-05 | 447 | 17 | 5 | int:SMAD3 | |
| Interaction | DDX1 interactions | 3.08e-05 | 463 | 17 | 5 | int:DDX1 | |
| Interaction | RARA interactions | 3.10e-05 | 223 | 17 | 4 | int:RARA | |
| Interaction | ERG interactions | 3.10e-05 | 223 | 17 | 4 | int:ERG | |
| Interaction | TGS1 interactions | 3.24e-05 | 75 | 17 | 3 | int:TGS1 | |
| Interaction | NANOG interactions | 3.70e-05 | 481 | 17 | 5 | int:NANOG | |
| Interaction | HNF1A interactions | 3.93e-05 | 80 | 17 | 3 | int:HNF1A | |
| Interaction | PPARGC1A interactions | 4.24e-05 | 82 | 17 | 3 | int:PPARGC1A | |
| Interaction | SOX7 interactions | 4.24e-05 | 82 | 17 | 3 | int:SOX7 | |
| Interaction | IRF1 interactions | 4.39e-05 | 83 | 17 | 3 | int:IRF1 | |
| Interaction | GSC interactions | 5.06e-05 | 87 | 17 | 3 | int:GSC | |
| Interaction | TBP interactions | 5.08e-05 | 253 | 17 | 4 | int:TBP | |
| Interaction | ASCL2 interactions | 5.20e-05 | 13 | 17 | 2 | int:ASCL2 | |
| Interaction | PCMT1 interactions | 5.31e-05 | 256 | 17 | 4 | int:PCMT1 | |
| Interaction | N4BP2 interactions | 5.41e-05 | 89 | 17 | 3 | int:N4BP2 | |
| Interaction | CPSF6 interactions | 5.67e-05 | 526 | 17 | 5 | int:CPSF6 | |
| Interaction | ESRRB interactions | 5.82e-05 | 262 | 17 | 4 | int:ESRRB | |
| Interaction | FOXI1 interactions | 5.98e-05 | 92 | 17 | 3 | int:FOXI1 | |
| Interaction | MED23 interactions | 6.17e-05 | 266 | 17 | 4 | int:MED23 | |
| Interaction | GRIP1 interactions | 6.79e-05 | 96 | 17 | 3 | int:GRIP1 | |
| Interaction | KLF2 interactions | 6.99e-05 | 15 | 17 | 2 | int:KLF2 | |
| Interaction | SS18L1 interactions | 7.22e-05 | 98 | 17 | 3 | int:SS18L1 | |
| Interaction | RBBP5 interactions | 8.28e-05 | 287 | 17 | 4 | int:RBBP5 | |
| Interaction | RBBP4 interactions | 8.51e-05 | 573 | 17 | 5 | int:RBBP4 | |
| Interaction | NFYA interactions | 8.86e-05 | 105 | 17 | 3 | int:NFYA | |
| Interaction | SOX2 interactions | 8.89e-05 | 1422 | 17 | 7 | int:SOX2 | |
| Interaction | MAML2 interactions | 9.04e-05 | 17 | 17 | 2 | int:MAML2 | |
| Interaction | FUBP3 interactions | 9.46e-05 | 297 | 17 | 4 | int:FUBP3 | |
| Interaction | SP7 interactions | 1.03e-04 | 304 | 17 | 4 | int:SP7 | |
| Interaction | PAX8 interactions | 1.05e-04 | 111 | 17 | 3 | int:PAX8 | |
| Interaction | THRA interactions | 1.05e-04 | 111 | 17 | 3 | int:THRA | |
| Interaction | CREBBP interactions | 1.05e-04 | 599 | 17 | 5 | int:CREBBP | |
| Interaction | PPARG interactions | 1.07e-04 | 307 | 17 | 4 | int:PPARG | |
| Interaction | KHSRP interactions | 1.09e-04 | 308 | 17 | 4 | int:KHSRP | |
| Interaction | NEUROG1 interactions | 1.14e-04 | 19 | 17 | 2 | int:NEUROG1 | |
| Interaction | SMG7 interactions | 1.25e-04 | 319 | 17 | 4 | int:SMG7 | |
| Interaction | SPIB interactions | 1.26e-04 | 20 | 17 | 2 | int:SPIB | |
| Interaction | DDIT3 interactions | 1.32e-04 | 120 | 17 | 3 | int:DDIT3 | |
| Interaction | RUNX1 interactions | 1.32e-04 | 324 | 17 | 4 | int:RUNX1 | |
| Interaction | ETS1 interactions | 1.35e-04 | 121 | 17 | 3 | int:ETS1 | |
| Interaction | CITED4 interactions | 1.39e-04 | 21 | 17 | 2 | int:CITED4 | |
| Interaction | HOXB4 interactions | 1.39e-04 | 21 | 17 | 2 | int:HOXB4 | |
| Interaction | PLAGL1 interactions | 1.39e-04 | 21 | 17 | 2 | int:PLAGL1 | |
| Interaction | KLF13 interactions | 1.39e-04 | 21 | 17 | 2 | int:KLF13 | |
| Interaction | ATXN1 interactions | 1.40e-04 | 1039 | 17 | 6 | int:ATXN1 | |
| Interaction | FOXO3 interactions | 1.45e-04 | 124 | 17 | 3 | int:FOXO3 | |
| Interaction | PAX7 interactions | 1.45e-04 | 124 | 17 | 3 | int:PAX7 | |
| Interaction | FAF1 interactions | 1.49e-04 | 334 | 17 | 4 | int:FAF1 | |
| Interaction | RUNX2 interactions | 1.52e-04 | 126 | 17 | 3 | int:RUNX2 | |
| Interaction | VDR interactions | 1.56e-04 | 127 | 17 | 3 | int:VDR | |
| Interaction | SRCAP interactions | 1.56e-04 | 127 | 17 | 3 | int:SRCAP | |
| Interaction | NUP50 interactions | 1.61e-04 | 341 | 17 | 4 | int:NUP50 | |
| Interaction | FHL1 interactions | 1.63e-04 | 129 | 17 | 3 | int:FHL1 | |
| Interaction | BMI1 interactions | 1.64e-04 | 659 | 17 | 5 | int:BMI1 | |
| Interaction | PAX9 interactions | 1.67e-04 | 130 | 17 | 3 | int:PAX9 | |
| Interaction | CITED2 interactions | 1.68e-04 | 23 | 17 | 2 | int:CITED2 | |
| Interaction | HOXD10 interactions | 1.68e-04 | 23 | 17 | 2 | int:HOXD10 | |
| Interaction | SMARCA2 interactions | 1.70e-04 | 346 | 17 | 4 | int:SMARCA2 | |
| Interaction | GCN1 interactions | 1.76e-04 | 349 | 17 | 4 | int:GCN1 | |
| Interaction | TBX21 interactions | 1.83e-04 | 24 | 17 | 2 | int:TBX21 | |
| Interaction | CNTN2 interactions | 1.83e-04 | 24 | 17 | 2 | int:CNTN2 | |
| Interaction | NR6A1 interactions | 1.83e-04 | 24 | 17 | 2 | int:NR6A1 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.98e-05 | 17 | 9 | 2 | 486 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.36e-05 | 18 | 9 | 2 | 91 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 4.77e-06 | 180 | 17 | 4 | M8239 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 7.24e-06 | 200 | 17 | 4 | M9188 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 7.24e-06 | 200 | 17 | 4 | M9628 | |
| Coexpression | BURTON_ADIPOGENESIS_1 | 1.82e-04 | 31 | 17 | 2 | M1612 | |
| Coexpression | BURTON_ADIPOGENESIS_1 | 1.82e-04 | 31 | 17 | 2 | MM1191 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.94e-04 | 32 | 17 | 2 | MM668 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.94e-04 | 32 | 17 | 2 | M1558 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 1.97e-04 | 467 | 17 | 4 | M1347 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | 2.26e-04 | 484 | 17 | 4 | MM999 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 2.59e-04 | 196 | 17 | 3 | M5381 | |
| Coexpression | GSE13306_TREG_VS_TCONV_UP | 2.67e-04 | 198 | 17 | 3 | M3229 | |
| Coexpression | GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 2.67e-04 | 198 | 17 | 3 | M9163 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 2.71e-04 | 199 | 17 | 3 | M9420 | |
| Coexpression | GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP | 2.71e-04 | 199 | 17 | 3 | M3217 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.75e-04 | 200 | 17 | 3 | M9449 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP | 2.75e-04 | 200 | 17 | 3 | M5134 | |
| Coexpression | GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN | 2.75e-04 | 200 | 17 | 3 | M4638 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 2.75e-04 | 200 | 17 | 3 | M4819 | |
| Coexpression | GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 2.75e-04 | 200 | 17 | 3 | M7981 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | 2.75e-04 | 200 | 17 | 3 | M7532 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 4.15e-04 | 568 | 17 | 4 | M4023 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_CPNs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.28e-07 | 198 | 17 | 4 | 4e598aab92141e7d32ec963291ddeed14a21beba | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.53e-05 | 186 | 17 | 3 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.53e-05 | 186 | 17 | 3 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.53e-05 | 186 | 17 | 3 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 4.83e-05 | 190 | 17 | 3 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.13e-05 | 194 | 17 | 3 | 920955e775617d6156c5ee8b90d2cecd01a70e12 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.21e-05 | 195 | 17 | 3 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.29e-05 | 196 | 17 | 3 | fe2dd3a93fe22da93e24a400e154a68757985fc8 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.37e-05 | 197 | 17 | 3 | d9a5b6171867de21d4ef12aa5a802fb4de9e0c00 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Serous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 197 | 17 | 3 | d3539607d5477f5dfd85f1fa99b74677c0fa8937 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Glandular-Serous-Serous|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 197 | 17 | 3 | 40bd7c314ff5254d87737822078e7b9eaf23edf3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.45e-05 | 198 | 17 | 3 | 3550798bfb9a426f3b28538a9778159bec2480d0 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.45e-05 | 198 | 17 | 3 | 8d7eb43b3e3b4a15265985143991e42afc20dc85 | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_CPNs|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.45e-05 | 198 | 17 | 3 | 32d58379a89be19b6b1a494bf033416546771c19 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | 94baf00dad27964392c3fc34970a4e79d576d0d3 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-Neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | b9538eb33ac86384e7e289a5a82fac4d56a7b9c2 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Cortical_neuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 7bba2ff09349c8db3d1ccf53520b12cbf7b0abac | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-04 | 103 | 17 | 2 | e28236a064a7c86e99e7e2edb1eb777f6034a9b4 | |
| ToppCell | (05)_Ciliated-(0)_uninjured|(05)_Ciliated / shred by cell type and Timepoint | 7.04e-04 | 104 | 17 | 2 | 0039ceeb70bec569b2d5e18be68f6c97973b80f5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.19e-04 | 119 | 17 | 2 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.03e-03 | 126 | 17 | 2 | 3539a8fdbb52d191f36dce68c38798ad4d2b491a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 133 | 17 | 2 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 133 | 17 | 2 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-03 | 134 | 17 | 2 | b5466759285b4973850afb2e1be7c1d25f1c7927 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.18e-03 | 135 | 17 | 2 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-Neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-03 | 136 | 17 | 2 | b46450292e0cd549eb3bafdd3fed22f41d85bfbe | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.34e-03 | 144 | 17 | 2 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-03 | 144 | 17 | 2 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Calb1_Sst|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.38e-03 | 146 | 17 | 2 | 10839a4fce2e62955a90592f927a6e0c6a84bbad | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Cortical_neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 1.42e-03 | 148 | 17 | 2 | a1269312903fc27830c1835dabf660c659a711be | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Akr1c18_Ntf3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-03 | 149 | 17 | 2 | 1e77f03d2b32f366018fec3462d1b75f6e7febb9 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-03 | 150 | 17 | 2 | aa11579a57d671a55e64183d35c1340fda6dec14 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-03 | 150 | 17 | 2 | ecc4fc94958cf2378dd003966dccba81b3c00f8e | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-03 | 153 | 17 | 2 | 82b77c8bae49dd63b8f10eb67df66ca71d0bb315 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Monocytes|Myeloid_cells / Location, Cell class and cell subclass | 1.55e-03 | 155 | 17 | 2 | 85eb60d285b8bfc095c341ae90c0e3b7e7dca9c1 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1-41|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.61e-03 | 158 | 17 | 2 | 6d2709b387945c015faa223c20d22b52a4082140 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gpr149_Islr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.63e-03 | 159 | 17 | 2 | c64fff8d89f84d1f5a0cc432e31f56f741162505 | |
| ToppCell | COVID-19_Moderate-MAIT|COVID-19_Moderate / disease group, cell group and cell class | 1.63e-03 | 159 | 17 | 2 | 6d08d670c34eb6bb8ad5dad3293b3107c006236d | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 160 | 17 | 2 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-03 | 160 | 17 | 2 | 21f7c0337fbd99e4a20650920d8302d7318bd25e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | db6b7ce6f7221bb73c5e650ac51cdd5d7ef00675 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-03 | 163 | 17 | 2 | 2d6fd2562d78be9f83fa35d811eb7e27eb8cc5d1 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.71e-03 | 163 | 17 | 2 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.73e-03 | 164 | 17 | 2 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | Int-URO-Myeloid-cDC1|Int-URO / Disease, Lineage and Cell Type | 1.73e-03 | 164 | 17 | 2 | f4628a7ff0dc765a5337ab499b3d61fc25573a16 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.75e-03 | 165 | 17 | 2 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-03 | 166 | 17 | 2 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-03 | 166 | 17 | 2 | b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.82e-03 | 168 | 17 | 2 | 2572a3dd4f3f619bd26a3cd6e60de43821d8bb64 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-03 | 171 | 17 | 2 | ea60d9e9df28ab991fbdb596784b44f6a9fc5827 | |
| ToppCell | Bac-SEP-Myeloid-cDC1|Bac-SEP / Disease, Lineage and Cell Type | 1.92e-03 | 173 | 17 | 2 | f88269327441858ddb8c49b9dd619b76fd53b1da | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 175 | 17 | 2 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 175 | 17 | 2 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.97e-03 | 175 | 17 | 2 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 176 | 17 | 2 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-03 | 176 | 17 | 2 | 7292e014b8f697f0c2e9f47c48333de95cb44a69 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.04e-03 | 178 | 17 | 2 | e5e4742e35c3d90f82b830d77bdbdc45828c7deb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 2.04e-03 | 178 | 17 | 2 | 7ac71e245864be2e8daecf555ff68235bd05827c | |
| ToppCell | facs-Tongue-nan-24m-Epithelial-basal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-03 | 178 | 17 | 2 | c92d7493853a717e2e7a76526e4e803564d182b7 | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-03 | 178 | 17 | 2 | 8151e5d73407fd9cba382b69a2bc707c81790c7f | |
| ToppCell | Mild-Treg|Mild / Disease group and Cell class | 2.04e-03 | 178 | 17 | 2 | e669fd95278e145f55126d0e6be8fb2d6184dbbd | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 2.08e-03 | 180 | 17 | 2 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 2.10e-03 | 181 | 17 | 2 | d2aa5b53162fb5c4cbbedbd2cb4b2b614e8c4afa | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.10e-03 | 181 | 17 | 2 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-03 | 181 | 17 | 2 | c029cecbd7182c70b9893d8c86f334c16291a0db | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-03 | 182 | 17 | 2 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-03 | 182 | 17 | 2 | 831b5ce46b41efe01c4db6016c2f43148611373d | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-03 | 182 | 17 | 2 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.13e-03 | 182 | 17 | 2 | a05e5978ef5f7fac7eeb2ba1c0103ea90d5e9136 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.15e-03 | 183 | 17 | 2 | 8c8ce5a0d5535bef58ac10b7eb726f9c50af2ed8 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_T-T_NK-Treg|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.15e-03 | 183 | 17 | 2 | 5fb933acfe6bc555c90dba71e75d4be658763945 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-03 | 184 | 17 | 2 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-03 | 184 | 17 | 2 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 2.17e-03 | 184 | 17 | 2 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | Serous|World / shred by cell class for bronchial biopsy | 2.17e-03 | 184 | 17 | 2 | 09d0d1525c11dd326efd942684c03f79d992cf3b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.17e-03 | 184 | 17 | 2 | 6e17c8151d6dc543de16d804db956c63c3fda414 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Serous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-03 | 184 | 17 | 2 | f0cbb5b76e092be4188a9804ef5cf7a83cd7644f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-03 | 184 | 17 | 2 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Serous-Serous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.17e-03 | 184 | 17 | 2 | 5433ba7bbab553ff668619822d1a9208e15cd59f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.17e-03 | 184 | 17 | 2 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | P28-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.17e-03 | 184 | 17 | 2 | 23c24ab5786af33d605bc445d06117b9da6c6331 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.17e-03 | 184 | 17 | 2 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-03 | 185 | 17 | 2 | 7aaa8335b40927e3e8fdcede807cd521fc213a0d | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_myogenic_precursor_(Axin2+)|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.20e-03 | 185 | 17 | 2 | b1e84228c95be8ccf7c3c1afb66b71ffb93cf61e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-03 | 185 | 17 | 2 | 2e1766f1a972fecd670daaaf7eb2d3a404f121e7 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.20e-03 | 185 | 17 | 2 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-03 | 186 | 17 | 2 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-03 | 186 | 17 | 2 | b87acc80b7baa41681e4ed11d5537b9fbf5832f5 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.22e-03 | 186 | 17 | 2 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.22e-03 | 186 | 17 | 2 | db9b67066fc003c7995ec205d15176bf40c97add | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_myocytic-stroma-muscle|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.22e-03 | 186 | 17 | 2 | b5c1afbe065746ed662527b2f052321f200ba0a8 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-03 | 187 | 17 | 2 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-03 | 187 | 17 | 2 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.26e-07 | 170 | 17 | 5 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.33e-07 | 172 | 17 | 5 | 1072_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.41e-07 | 174 | 17 | 5 | 1659_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.45e-07 | 175 | 17 | 5 | 1058_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.54e-07 | 177 | 17 | 5 | 1645_DN | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 5.24e-06 | 5 | 17 | 2 | ctd:C575894 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.09e-06 | 173 | 17 | 4 | 2881_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 7.42e-06 | 175 | 17 | 4 | 1014_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.76e-06 | 177 | 17 | 4 | 3227_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.76e-06 | 177 | 17 | 4 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 7.94e-06 | 178 | 17 | 4 | 4184_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 7.94e-06 | 178 | 17 | 4 | 1112_DN | |
| Drug | fisetin; Down 200; 50uM; PC3; HG-U133A | 7.94e-06 | 178 | 17 | 4 | 579_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 8.30e-06 | 180 | 17 | 4 | 6886_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.30e-06 | 180 | 17 | 4 | 4821_DN | |
| Drug | dimethylurea | 2.35e-05 | 10 | 17 | 2 | CID000007293 | |
| Drug | AC1L2E0P | 6.72e-05 | 307 | 17 | 4 | CID000019390 | |
| Drug | 4,4'-DBP | 8.91e-05 | 19 | 17 | 2 | CID000007034 | |
| Drug | 4-pyridoxic acid | 1.32e-04 | 23 | 17 | 2 | CID000006723 | |
| Drug | SB 203580 | 1.66e-04 | 388 | 17 | 4 | ctd:C093642 | |
| Drug | AGN 194204 | 2.23e-04 | 162 | 17 | 3 | ctd:C430898 | |
| Drug | calmidazolium chloride; Up 200; 5uM; MCF7; HG-U133A | 2.36e-04 | 165 | 17 | 3 | 486_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.57e-04 | 170 | 17 | 3 | 3746_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 2.62e-04 | 171 | 17 | 3 | 1000_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.62e-04 | 171 | 17 | 3 | 6879_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.66e-04 | 172 | 17 | 3 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.71e-04 | 173 | 17 | 3 | 5987_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.71e-04 | 173 | 17 | 3 | 4237_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.71e-04 | 173 | 17 | 3 | 4458_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.76e-04 | 174 | 17 | 3 | 909_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.85e-04 | 176 | 17 | 3 | 981_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.90e-04 | 177 | 17 | 3 | 873_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.90e-04 | 177 | 17 | 3 | 6434_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.95e-04 | 178 | 17 | 3 | 7245_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 2.95e-04 | 178 | 17 | 3 | 4444_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.00e-04 | 179 | 17 | 3 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.00e-04 | 179 | 17 | 3 | 5822_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.05e-04 | 180 | 17 | 3 | 3688_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.05e-04 | 180 | 17 | 3 | 4541_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.10e-04 | 181 | 17 | 3 | 6951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 3.15e-04 | 182 | 17 | 3 | 1891_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 3.15e-04 | 182 | 17 | 3 | 1951_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.20e-04 | 183 | 17 | 3 | 7136_DN | |
| Drug | glutamin | 3.20e-04 | 461 | 17 | 4 | CID000000738 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 3.25e-04 | 184 | 17 | 3 | 5671_DN | |
| Drug | S x H | 3.26e-04 | 36 | 17 | 2 | CID009549209 | |
| Drug | H-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A | 3.51e-04 | 189 | 17 | 3 | 5936_DN | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A | 3.51e-04 | 189 | 17 | 3 | 3690_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.62e-04 | 191 | 17 | 3 | 7503_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 3.68e-04 | 192 | 17 | 3 | 2919_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 4186_DN | |
| Drug | Zaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 6749_DN | |
| Drug | Glipizide [29094-61-9]; Down 200; 9uM; PC3; HG-U133A | 3.74e-04 | 193 | 17 | 3 | 1926_DN | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 3347_UP | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.74e-04 | 193 | 17 | 3 | 2829_UP | |
| Drug | Skimmianine [83-95-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 2504_UP | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; HL60; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 1856_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 3861_DN | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 6235_UP | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; PC3; HG-U133A | 3.85e-04 | 195 | 17 | 3 | 1922_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HG-U133A | 3.91e-04 | 196 | 17 | 3 | 203_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6954_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6757_DN | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 4766_DN | |
| Drug | Amyleine hydrochloride [532-59-2]; Down 200; 14.8uM; PC3; HG-U133A | 3.91e-04 | 196 | 17 | 3 | 1909_DN | |
| Drug | Pentetic acid [67-43-6]; Down 200; 10.2uM; HL60; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 3049_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 2324_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3357_UP | |
| Drug | Iodixanol [92339-11-2]; Up 200; 2.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 3362_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 4751_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5456_UP | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Down 200; 8.6uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 4193_DN | |
| Drug | ST021200; Down 200; 10uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 7554_DN | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 4185_DN | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 7383_UP | |
| Drug | Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3505_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 50uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6982_DN | |
| Drug | CGX 0596987; Down 200; 20uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 6364_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 4228_DN | |
| Drug | Pyrilamine maleate [59-33-6]; Up 200; 10uM; HL60; HG-U133A | 4.09e-04 | 199 | 17 | 3 | 1568_UP | |
| Drug | Yohimbine hydrochloride [65-19-0]; Down 200; 10.2uM; HL60; HG-U133A | 4.09e-04 | 199 | 17 | 3 | 1763_DN | |
| Drug | LY294002; Down 200; 10uM; MCF7; HG-U133A | 4.09e-04 | 199 | 17 | 3 | 258_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 3354_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 2323_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Up 200; 10.8uM; PC3; HG-U133A | 4.15e-04 | 200 | 17 | 3 | 1939_UP | |
| Drug | Promethazine hydrochloride [58-33-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 6477_UP | |
| Drug | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 4.23e-04 | 41 | 17 | 2 | ctd:D019307 | |
| Drug | N-methylmesoporphyrin | 4.44e-04 | 42 | 17 | 2 | CID000444708 | |
| Drug | Phlorhizin | 6.63e-04 | 235 | 17 | 3 | ctd:D010695 | |
| Disease | Menke-Hennekam syndrome | 3.12e-07 | 2 | 17 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 3.12e-07 | 2 | 17 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 3.12e-07 | 2 | 17 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.12e-07 | 2 | 17 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 3.12e-07 | 2 | 17 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 3.12e-07 | 2 | 17 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 3.12e-07 | 2 | 17 | 2 | cv:C4551859 | |
| Disease | Rubinstein-Taybi Syndrome | 3.12e-07 | 2 | 17 | 2 | C0035934 | |
| Disease | Carcinoma, Transitional Cell | 1.67e-06 | 41 | 17 | 3 | C0007138 | |
| Disease | Small cell carcinoma of lung | 3.87e-06 | 54 | 17 | 3 | C0149925 | |
| Disease | Adenoid Cystic Carcinoma | 2.48e-05 | 100 | 17 | 3 | C0010606 | |
| Disease | T-Cell Lymphoma | 3.73e-05 | 16 | 17 | 2 | C0079772 | |
| Disease | Bladder Neoplasm | 6.77e-05 | 140 | 17 | 3 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.92e-05 | 141 | 17 | 3 | C0005684 | |
| Disease | Paroxysmal atrial fibrillation | 9.33e-05 | 156 | 17 | 3 | C0235480 | |
| Disease | Persistent atrial fibrillation | 9.33e-05 | 156 | 17 | 3 | C2585653 | |
| Disease | familial atrial fibrillation | 9.33e-05 | 156 | 17 | 3 | C3468561 | |
| Disease | Atrial Fibrillation | 1.01e-04 | 160 | 17 | 3 | C0004238 | |
| Disease | Sezary Syndrome | 1.09e-04 | 27 | 17 | 2 | C0036920 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.81e-04 | 195 | 17 | 3 | DOID:1574 (implicated_via_orthology) | |
| Disease | colon cancer (is_implicated_in) | 1.95e-04 | 36 | 17 | 2 | DOID:219 (is_implicated_in) | |
| Disease | Breast adenocarcinoma | 2.53e-04 | 41 | 17 | 2 | C0858252 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.53e-04 | 41 | 17 | 2 | C0496956 | |
| Disease | Diffuse Large B-Cell Lymphoma | 4.56e-04 | 55 | 17 | 2 | C0079744 | |
| Disease | C-reactive protein measurement | 4.64e-04 | 1206 | 17 | 5 | EFO_0004458 | |
| Disease | pre-eclampsia (is_marker_for) | 5.07e-04 | 58 | 17 | 2 | DOID:10591 (is_marker_for) | |
| Disease | Endometrial Neoplasms | 5.07e-04 | 58 | 17 | 2 | C0014170 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 5.60e-04 | 61 | 17 | 2 | C1961102 | |
| Disease | Endometrial Carcinoma | 7.80e-04 | 72 | 17 | 2 | C0476089 | |
| Disease | risk-taking behaviour | 8.11e-04 | 764 | 17 | 4 | EFO_0008579 | |
| Disease | neutrophil count | 8.63e-04 | 1382 | 17 | 5 | EFO_0004833 | |
| Disease | irritability measurement | 1.01e-03 | 82 | 17 | 2 | EFO_0009594 | |
| Disease | beverage consumption measurement | 1.03e-03 | 83 | 17 | 2 | EFO_0010088 | |
| Disease | Squamous cell carcinoma of esophagus | 1.35e-03 | 95 | 17 | 2 | C0279626 | |
| Disease | urate measurement | 1.46e-03 | 895 | 17 | 4 | EFO_0004531 | |
| Disease | triglyceride measurement, alcohol drinking | 1.47e-03 | 99 | 17 | 2 | EFO_0004329, EFO_0004530 | |
| Disease | triglyceride measurement, alcohol consumption measurement | 1.53e-03 | 101 | 17 | 2 | EFO_0004530, EFO_0007878 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 1.71e-03 | 107 | 17 | 2 | EFO_0004614, EFO_0004615 | |
| Disease | creatinine measurement, glomerular filtration rate | 2.04e-03 | 117 | 17 | 2 | EFO_0004518, EFO_0005208 | |
| Disease | Squamous cell carcinoma | 2.29e-03 | 124 | 17 | 2 | C0007137 | |
| Disease | IGF-1 measurement | 2.57e-03 | 488 | 17 | 3 | EFO_0004627 | |
| Disease | Malignant neoplasm of breast | 2.84e-03 | 1074 | 17 | 4 | C0006142 | |
| Disease | breast cancer (is_implicated_in) | 3.32e-03 | 150 | 17 | 2 | DOID:1612 (is_implicated_in) | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 3.63e-03 | 157 | 17 | 2 | DOID:224 (biomarker_via_orthology) | |
| Disease | alcohol consumption measurement, high density lipoprotein cholesterol measurement | 3.86e-03 | 162 | 17 | 2 | EFO_0004612, EFO_0007878 | |
| Disease | alcohol drinking, high density lipoprotein cholesterol measurement | 4.14e-03 | 168 | 17 | 2 | EFO_0004329, EFO_0004612 | |
| Disease | Leukemia, Myelocytic, Acute | 4.39e-03 | 173 | 17 | 2 | C0023467 | |
| Disease | FEV/FEC ratio | 4.60e-03 | 1228 | 17 | 4 | EFO_0004713 | |
| Disease | Adenocarcinoma of lung (disorder) | 6.16e-03 | 206 | 17 | 2 | C0152013 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NMGQQPAPQVQQPGL | 301 | Q09472 | |
| QQNQQPGQSPQGMRP | 491 | Q09472 | |
| PQQQPQQQLQPPMGG | 2146 | Q09472 | |
| MPPGQWQQAPLPQQQ | 2016 | Q92793 | |
| NQPGMQPQPGLQSQP | 2111 | Q92793 | |
| QPQPGLQSQPGMQPQ | 2116 | Q92793 | |
| QQQVQPPQPQMAGPL | 531 | Q9UBL0 | |
| QQVLPPQGYMQPPQQ | 501 | Q9Y2K5 | |
| VVMQLNVPNGPQPPQ | 706 | Q9Y2K5 | |
| GQGQPQQQQLPPAQP | 1396 | O14497 | |
| QGMQGPPVPQFQPQK | 6 | Q8TDX7 | |
| QQALQAQPPIQQPPM | 261 | Q96RN5 | |
| QQMGPRPPQNNPLPQ | 451 | Q14686 | |
| PPNFMVMQQQPPNQG | 486 | Q14686 | |
| QGPPQQGGQQQQGPP | 71 | P02810 | |
| GGPQPPPTQQGQQQA | 696 | Q92945 | |
| LQPQPPQIQNGPMNG | 96 | Q9NUQ6 | |
| APPPQQLQYGQQQPM | 621 | Q15714 | |
| QQVIPQMQPGGVQAP | 186 | P52655 | |
| KPQGPPQQEGNNPQG | 341 | P04280 | |
| QQQQPGQGPAEPSQP | 201 | Q8WV24 | |
| GVMLDPLQQQQPPQP | 531 | Q96JM2 | |
| QPPQGQNGSMLPNQP | 361 | P31483 | |
| MQQPQPQGQQQPGPG | 1 | Q7Z7E8 |